Many people with implantable defibrillators can participate in vigorous sports
Many people with implantable defibrillators can safely participate in vigorous sports according to new research in the American Heart Association journal Circulation.
Health
21 hours ago |
not rated yet |
0
Australia: Stroke rates decline, but many still preventable
The rate of strokes suffered by Australians has dropped over the past 20 years, while strokes caused by an irregular heartbeat now account for one third of all strokes, according to new research led by the University of Adelaide.
Cardiology
May 16, 2013 |
not rated yet |
0
Swimming pools may pose hazard for people with heart devices
(HealthDay)—With summer approaching, researchers caution that swimming pools may pose a risk to patients with irregular heartbeats who've received implantable defibrillators.
Cardiology
May 09, 2013 |
not rated yet |
0
Kcentra approved to stop severe bleeding in heart patients
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
Medications
Apr 30, 2013 |
not rated yet |
0
Arrhythmia drug may increase cancer risk
One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men and people exposed to high amounts of the drug. That is the conclusion of a new retrospective study ...
Cancer
Apr 08, 2013 |
not rated yet |
0
|
World's most detailed 3-D computer model of heart chambers
Researchers from The University of Auckland have developed the world's most detailed 3D computer models of the heart's upper chambers.
Cardiology
Apr 04, 2013 |
5 / 5 (2) |
0
Energy drinks may increase blood pressure, disturb heart rhythm
Energy drinks may increase blood pressure and disturb your heart's natural rhythm, according to research presented at the American Heart Association's Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism ...
Cardiology
Mar 21, 2013 |
4 / 5 (1) |
0
Outside the box: Team uses brain aneurysm treatment to stop irregular heart rhythms
For the first time, a UCLA team has used a technique normally employed in treating brain aneurysms to treat severe, life-threatening irregular heart rhythms in two patients.
Cardiology
Mar 14, 2013 |
5 / 5 (3) |
0
|
FDA adds heart risk warning to popular antibiotic Zithromax
The Food and Drug Administration is warning doctors and patients that a widely used antibiotic from Pfizer can cause rare but deadly heart rhythms in some patients.
Medications
Mar 12, 2013 |
not rated yet |
0
Stroke prevention device misses key goal in study
The future is unclear for a promising heart device aimed at preventing strokes in people at high risk of them because of an irregular heartbeat.
Cardiology
Mar 09, 2013 |
not rated yet |
0
Clogged heart arteries can foreshadow stroke
Blockages in your heart arteries could mean you're more likely to have a stroke, even if you're considered low risk, according to research in the American Heart Association journal Stroke.
Cardiology
Feb 28, 2013 |
5 / 5 (1) |
0
FDA clears anticlotting drug Eliquis
The Food and Drug Administration says it has approved the anticlotting drug Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc. It's a potential blockbuster drug in a new category of medicines to prevent strokes ...
Medications
Dec 28, 2012 |
not rated yet |
0
Bristol-Myers, Pfizer's Eliquis approved in Japan
Regulators in Japan have approved sales of an anticlotting drug called Eliquis, developed by Bristol-Myers Squibb Co. and Pfizer Inc., that's a potential blockbuster in a new category of medicines to prevent strokes and heart ...
Medications
Dec 26, 2012 |
not rated yet |
0
How dangerous are energy drinks for young people?
(Medical Xpress)—News reports broke this week that since 2003, three Canadian teens have died from drinking energy drinks, and 35 others have suffered series side effects like amnesia and irregular heartbeat. ...
Health
Nov 21, 2012 |
not rated yet |
0
Bristol-Pfizer anticlot drug gets key EU approval
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system.
Medications
Nov 20, 2012 |
5 / 5 (2) |
0
